Monoamine oxidase (MAO) inhibitors have long been used to effectively treat depression, particularly atypical depression (also known as depression with atypical features or DSM) that is characterized by an improved mood due to positive events.
MAOIs also help treat Parkinson's Disease, migraineprophylaxis, and a host of other disorders: panic disorder with agoraphobia, social phobia, bulimia, post-traumatic stress disorder, borderline personality disorder, and bipolar depression. There have also been reports of their efficacy in obsessive-compulsive disorder, trichotillomania, dysmorphophobia, and avoidant personality disorder, although these results have yet to be clarified and confirmed as real and credible.
While effective, MAOIs have been pushed to the back as a last-line treatment. It has been known to have some potentially lethal dietary side effects and drug interactions. However, recent medical findings show that these negative information may have caused MAOIs to be misunderstood and underultilized.
LEARN MORE about MAOIs here and let us know of any concerns you might have.